Beyond Mobile Medical App Guidance

Broadcast in Business

Call in to speak with the host

(347) 996-5894

h:755
s:4610993
archived
Pharmaguy

Pharmaguy

×  

Follow This Show

If you liked this show, you should follow Pharmaguy.

What to Worry About After FDA Publishes Its "Final" Guidelines

A conversation with Bradley Merrill Thompson, Member of the Firm at Epstein Becker & Green and General Counsel to the mHealth Regulatory Coalition. We discuss prospects for FDA's final guidance on regulation of mobile medical apps (MMAs) and other regulatory issues that the mobile health community and FDA will need to face after publication of the "final" guidelines.

Comments

 comments